The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.375
Bid: 4.25
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 0.25 (5.882%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4.375
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: IPF Rises As June Collections Improve

Fri, 10th Jul 2020 10:43

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.

----------

FTSE 100 - WINNERS

----------

Barclays, up 1.2%. Investec raised the lender to Buy from Hold.

----------

FTSE 250 - WINNERS

----------

Petropavlovsk, up 3.0%. The gold miner said Non-Executive Chair Peter Hambro, Chief Executive Alya Samokhvalova, Non-Executive Directors Johnny Smith, Martin Smith and Angelica Phillips will remain directors of the firm after the court requested a full hearing of Everest Alliance Ltd's application to remove them from their roles. Petropavlovsk said that while the judge found that Everest's complaints that the directors were not validly appointed were arguable, he declined to determine its application summarily and instead now requires a full hearing of Everest's application. Earlier on Friday, Everest - which has a 7.5% stake - requisitioned a general meeting to propose the hire of two new directors. The resolutions to be put forth at the meeting requested include the appointment of Paul Bushell and Ivan Kulakov as directors, the re-hire of James Cameron, Charlotte Phillipps, Katia Ray and Maxim Kharin in the event they have been removed as directors. Everest is looking to remove Hambro, Samokhvalova, Johnny Smith, Martin Smith and Phillips from the board. Everest also wants the removal of any other director that may have been appointed since Thursday until the end of the requisitioned meeting.

----------

FTSE 250 - LOSERS

----------

Senior, down 2.8%. The technology components manufacturer expressed a confident outlook going forward despite expecting to report a revenue fall in the first half of 2020. Senior reported a "robust" cash performance in the six months to the end of June, with GBP3 million net cash inflow generated during the period, in the face of "significant disruption" to its end markets. The company said it now expects revenue in the first half of 2020 to be around 30% lower than GBP580.4 million generated in the first half of 2019. Senior said net debt is expected to be GBP239 million at June 30, an improvement of GBP3 million from the end of December 2019. In 2019, in order to counter the anticipated decline in sales, Senior initiated a restructuring plan. Reflecting the additional actions which the company is taking, it now expects the total restructuring charge to be up to GBP35 million, an increase from the GBP23 million originally anticipated. Going forward, Senior said trading for the rest of 2020 continues to be hurt by Covid-19. As a result, guidance for 2020 remains suspended.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Marston's, up 2.5%. JPMorgan resumed the brewer with Neutral.

----------

International Personal Finance, up 15%. The home credit business said it is "well-placed" going forward as its collections effectiveness continued to improve in June. The company said it is encouraged by the extent to which the company is now stabilising into a "new normal" operational environment. International Personal Finance said collections effectiveness continued to improve in June, reaching 88% of pre-Covid expectations. It was at 76% in April and 80% in May. Going forward, the company said it expects collections effectiveness to progressively improve in the coming months. International Personal Finance said there is a continuing strong demand for its products. As lockdown restrictions are progressively relaxed and the company's collections effectiveness is improved, it said it has increased credit issued. In June, the company lent 37% of pre-Covid expectations, up from 30% during both of April and May.

----------

SRT Marine Systems, up 19%. The maritime surveillance provider announced the resumption of its Philippines fisheries management system project, with a significant cash payment being received in the week. The revised Philippines project plan agreed with SRT's customer is looking to accelerate implementation to make up for as much time lost as possible due to the five month pause. Meanwhile, in the Middle East final contract negotiations have recommenced and subject to completion of internal processes, these are expected to conclude soon with the projects starting in the coming months. Finally, SRT's Transcievers business has performed better than expected despite the current circumstances, achieving gross sales in the first quarter ended June 30 up 2% from the same period the year before.

----------

Focusrite, up 6.1%. The AIM-listed music & audio products company said revenue and profit are currently ahead of the company's expectations for the year to the end of August. Focusrite noted that the demand for its Audio Engineering and ADAM Audio products has been strong during the widespread lockdowns that have occurred as a result of Covid-19, thanks to widespread availability globally through e-commerce platforms. In addition, consumer registrations of products primarily focused on home recording equipment have risen. Conversely, demand for Martin Audio products has been significantly lower than pre-Covid levels of expectation due to the suspension of live music tours and festivals, although demand is now starting to show modest signs of recovery driven by the installed sound segment. Similarly, Focusrite Pro has seen muted performance as well, although the pipeline across education, post-production and installed sound is now showing signs of recovery.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Genedrive, down 13%. The molecular diagnostics firm expects its full year revenue to be sharply lower but in line with internal guidance. For the year to June 30, Genedrive expects its revenue to come in at GBP1.0 million from GBP2.4 million the year before. Looking ahead, Genedrive said it has received "significant" interest in its 96 SARS-CoV-2 kit, but obtaining regulatory approval is "taking longer than anticipated" and the regulatory agencies the firm is dealing with is "unable to provide definitive timelines for approvals".

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
20 Dec 2023 11:07

AIM WINNERS & LOSERS: Genedrive shares jump on orders

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
20 Dec 2023 10:49

IN BRIEF: Genedrive shares surge as six countries receive first orders

Genedrive PLC - Manchester, England-based molecular diagnostics company - Says initial orders of its MT-RNR1 products from France, Austria, the Netherlands, Greece, Saudi Arabia and Turkey have been received. News follows confirmation that commercial distribution agreements were signed in multiple countries for Genedrive's test for antibiotic induced hearing loss. Genedrive says these initial orders will support its international distribution partners in promotion and in-country evaluation activities in their respective countries. Hopes this will "provide more extensive access to this life-changing test."

Read more
4 Dec 2023 17:33

TRADING UPDATES: 600 Group disposal and funding talks continue

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
30 Nov 2023 10:03

Genedrive shares fall as annual loss widens but focused on investing

(Alliance News) - Genedrive PLC on Thursday reported a widened loss but said it remains focused on investing in product development, focusing on maximising the benefits of its platform.

Read more
29 Nov 2023 21:36

EARNINGS AND TRADING: Southern Energy loss swing; Craven House widens

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
23 Nov 2023 15:54

UK earnings, trading statements calendar - next 7 days

Friday 24 November 
no events scheduled 
Monday 27 November 
Celebrus Technologies PLCHalf Year Results
DSW Capital PLCHalf Year Results
JLEN Environmental Assets Group LtdHalf Year Results
Northern Bear PLCHalf Year Results
Rightmove PLCTrading Statement
Serinus Energy PLCQ3 Results
SysGroup PLCHalf Year Results
Tuesday 28 November 
Altitude Group PLCHalf Year Results
Augmentum FintechHalf Year Results
Brickability Group PLCHalf Year Results
DP Eurasia NVTrading Statement
easyJet PLCFull Year Results
Focusrite PLCFull Year Results
Greencore Group PLCFull Year Results
IG Design Group PLCHalf Year Results
Kinovo PLCHalf Year Results
Loungers PLCHalf Year Results
Mercia Asset Management PLCHalf Year Results
Pets At Home Group PLCHalf Year Results
Renew Holdings PLCFull Year Results
Safestore Holdings PLCTrading Statement
Supreme PLCHalf Year Results
Topps Tiles PLCFull Year Results
Treatt PLCFull Year Results
Vp PLCHalf Year Results
Wednesday 29 November 
Amaroq Minerals LtdQ3 Results
Benchmark Holdings PLCFull Year Results
Braemar PLCHalf Year Results
Cordiant Digital Infrastructure LtdHalf Year Results
CVS Group PLCTrading Statement
Halfords Group PLCHalf Year Results
Harbour Energy PLCTrading Statement
Pennon Group PLCHalf Year Results
Vinanz LtdQ3 Results
Thursday 30 November 
Carclo PLCHalf Year Results
Dr Martens PLCHalf Year Results
Genedrive PLCFull Year Results
James Latham PLCHalf Year Results
LXi REIT PLCHalf Year Results
ME Group International PLCTrading Statement
TClarke PLCTrading Statement
Tharisa PLCFull Year Results
Walker Crips Group PLCHalf Year Results
Zoo Digital Group PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
28 Sep 2023 16:09

IN BRIEF: Genedrive to receive GBP1.2 million grant for test kit

Genedrive PLC - Manchester-based molecular diagnostics company - Confirms that it expects to benefit from GBP1.2 million of funding, through its participation in a multi-partner grant award from Innovate UK and the UK government Innovation Accelerator programme. The grant, which is for the development and validation of technology for time critical genomic testing, will provide Genedrive with acute care patient access and supporting infrastructure to assess the real world clinical performance of time-critical clinical tests in NHS settings.

Read more
11 Sep 2023 15:21

Genedrive appoints new chief executive and chief scientific officer

(Alliance News) - Genedrive PLC on Monday said it appointed James Cheek as its new chief executive officer, effective immediately.

Read more
6 Sep 2023 13:55

Genedrive diagnostic test system gets UKCA registration

(Sharecast News) - Point-of-care molecular diagnostics developer Genedrive announced on Wednesday that its Genedrive CYP2C19 System has received UKCA marking registration.

Read more
6 Sep 2023 11:18

Genedrive shares jump as hails UKCA mark for test; aims for EU CE mark

(Alliance News) - Genedrive PLC on Wednesday said that its CYP2C19 point of care test achieved marking registration in the UK, known as UKCA.

Read more
5 Jul 2023 15:30

TRADING UPDATES: RTW plans buyback; Octopus AIM VCTs eye fundraise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 Jul 2023 14:41

Genedrive draws down £0.3m under equity prepayment facility

(Sharecast News) - Molecular diagnostics company Genedrive announced the latest drawdown of £0.3m under its £5m equity prepayment facility on Wednesday.

Read more
16 Jun 2023 10:49

Genedrive secures multi-partner grant award

(Sharecast News) - Molecular diagnostics specialist Genedrive announced its involvement in a multi-partner grant award called DEVOTE on Friday, supported by Innovate UK and the UK government's Innovation Accelerator programme.

Read more
16 Jun 2023 10:29

AIM WINNERS & LOSERS: Marlowe up on report of potential division sale

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
16 Jun 2023 09:27

IN BRIEF: Genedrive shares up as UK government grant received

Genedrive PLC - Manchester, England-based point-of-care molecular diagnostics company - Awarded a multi-partner grant for the validation of its CYP2X19 ID kit from Innovate UK and the UK government Innovation Accelerator programme. Says the 'Devote' grant will allow it to offer critical clinical tests in NHS settings.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.